Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Nevro's Business Segments
Nevro's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 408
Regions Reported
1
Annual Results
Revenue Share by Reportable Segment - FY2024
- Reportable0%
Revenue by Reportable Segment - FY2024
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 409 | - |
Revenue Share by Region - FY2024
- Non-US13.6%
Revenue by Geographic Region - FY2024
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 55 | 13.6% |
Description of Nevro
Nevro Corp is a medical technology company that specializes in the development and commercialization of innovative spinal cord stimulation therapies for patients suffering from chronic pain. The company was founded in 2006 and is headquartered in Redwood City, California. Nevro's flagship product is the Senza system, which uses high-frequency spinal cord stimulation to provide long-lasting pain relief to patients.
The Senza system works by delivering electrical pulses to the nerve fibers in the spinal cord, which disrupt the pain signals that are being sent from the affected area of the body to the brain. This results in significant and sustained relief from chronic pain, without the need for opioids or other potentially addictive medications. The Senza system is designed to be highly customizable to the individual patient's needs, with a range of different stimulation options and programming settings available.
Nevro has a strong commitment to research and development, with a dedicated team working to continually improve the Senza system and explore new approaches to pain management. The company has invested heavily in large-scale clinical trials to demonstrate the safety and effectiveness of its technology, and has published numerous peer-reviewed studies in leading medical journals.
In addition to the Senza system, Nevro offers a range of related products and services, including training and support for healthcare providers, patient education resources, and clinical research collaboration opportunities. The company has a global presence, with operations in Europe, Asia-Pacific, and North America, and is actively expanding its reach into new markets and treatment areas.
Overall, Nevro Corp is a pioneering medical technology company that is making a major impact in the field of pain management. With its innovative spinal cord stimulation technology, commitment to research and development, and global reach, Nevro is a leading player in this fast-growing market.
The Senza system works by delivering electrical pulses to the nerve fibers in the spinal cord, which disrupt the pain signals that are being sent from the affected area of the body to the brain. This results in significant and sustained relief from chronic pain, without the need for opioids or other potentially addictive medications. The Senza system is designed to be highly customizable to the individual patient's needs, with a range of different stimulation options and programming settings available.
Nevro has a strong commitment to research and development, with a dedicated team working to continually improve the Senza system and explore new approaches to pain management. The company has invested heavily in large-scale clinical trials to demonstrate the safety and effectiveness of its technology, and has published numerous peer-reviewed studies in leading medical journals.
In addition to the Senza system, Nevro offers a range of related products and services, including training and support for healthcare providers, patient education resources, and clinical research collaboration opportunities. The company has a global presence, with operations in Europe, Asia-Pacific, and North America, and is actively expanding its reach into new markets and treatment areas.
Overall, Nevro Corp is a pioneering medical technology company that is making a major impact in the field of pain management. With its innovative spinal cord stimulation technology, commitment to research and development, and global reach, Nevro is a leading player in this fast-growing market.
Nevro Corp is a pioneering medical technology company dedicated to revolutionizing the treatment landscape for chronic pain management. The company has focused its efforts on developing innovative solutions that harness the power of spinal cord stimulation, particularly through its proprietary Senza system. This commitment not only addresses pain relief but also elevates the overall quality of life for patients suffering from chronic conditions.
Segments
Nevro Corp operates primarily within the healthcare segment dedicated to the development, manufacturing, and sale of advanced medical devices aimed specifically at managing chronic pain. This segment encompasses the following areas:
1. Spinal Cord Stimulation: This is the primary focus of Nevros business, with a specific emphasis on high-frequency stimulation designed to block pain signals effectively.
2. Therapeutics and Pain Management: The company recognizes the multifaceted nature of pain management, integrating its products into broader therapeutic strategies alongside physical therapy, medication, and other interventions.
3. Clinical Research and Development: Nevro invests substantially in clinical trials to assess the efficacy and safety of its devices and explore new therapeutic applications, thereby reinforcing its commitment to innovation.
4. Education and Training: An essential aspect of Nevros operations involves educating healthcare providers and patients alike about the capabilities of their products and the science behind chronic pain management.
Products
Nevro Corps product lineup is centered around the high-frequency spinal cord stimulation technology, with the Senza system being the flagship offering. Here’s a closer look at the specific products:
1. Senza Spinal Cord Stimulation System:
- Neurostimulator: A compact implantable device that delivers high-frequency electrical impulses targeting the spinal cord.
- Handheld Remote Control: Patients can control and adjust the stimulator settings based on their comfort levels and pain management needs.
2. Senza Omnia:
- This system offers customizable stimulation parameters, enabling healthcare providers to tailor therapy for individual patient needs in a more personalized approach.
3. Senza II:
- An upgraded version of the original Senza system featuring enhanced battery life and improved therapeutic outcomes, designed to extend the usability and functionality for patients.
4. HF10 Therapy:
- Utilizes a proprietary waveforms technology, designed to provide effective pain relief without the undesirable sensations of paresthesia, which can be a common side effect of traditional stimulation methods.
5. Senza SCS:
- Specifically targeted toward patients with a high pain burden, this spinal cord stimulation system is optimized for those who may not have achieved adequate relief from conventional pain management strategies.
6. Accessories and Consumables:
- Nevro provides various accessories that support the operation of its devices, ensuring patients have the necessary tools for optimal use.
Services
Complementing its product offerings, Nevro Corp extends a range of services that enhance the overall patient experience and optimize clinical outcomes:
1. Clinical Research:
- Nevro engages in rigorous, ongoing research to validate the effectiveness of its products and explore new therapeutic possibilities, ensuring that its offerings remain at the forefront of medical innovation.
2. Physician Training:
- The company provides extensive training and certification programs for healthcare providers to ensure they are well-equipped to integrate Nevros technologies into their practices.
3. Patient Education:
- A suite of educational resources is available to help patients navigate their treatment options, understand the mechanisms of their therapies, and make informed decisions regarding their chronic pain management.
4. Technical Support:
- Dedicated technical support services are in place to assist both patients and healthcare providers with any operational inquiries or troubleshooting needs concerning the Senza system.
5. Patient Advocacy:
- Nevro is deeply committed to advocating for chronic pain sufferers, working collaboratively with patient advocacy groups to elevate awareness about the challenges faced by this population and promote resources for support.
Conclusion
In summary, Nevro Corp stands as a leader in the field of chronic pain management through its innovative products and comprehensive services. The Senza system, along with its associated offerings, highlight the companys dedication to providing effective and personalized pain relief solutions. By concentrating on ongoing clinical research, comprehensive education, and unwavering patient advocacy, Nevro strives to not only alleviate suffering but also enhance the quality of life for individuals facing the challenges of chronic pain.
Segments
Nevro Corp operates primarily within the healthcare segment dedicated to the development, manufacturing, and sale of advanced medical devices aimed specifically at managing chronic pain. This segment encompasses the following areas:
1. Spinal Cord Stimulation: This is the primary focus of Nevros business, with a specific emphasis on high-frequency stimulation designed to block pain signals effectively.
2. Therapeutics and Pain Management: The company recognizes the multifaceted nature of pain management, integrating its products into broader therapeutic strategies alongside physical therapy, medication, and other interventions.
3. Clinical Research and Development: Nevro invests substantially in clinical trials to assess the efficacy and safety of its devices and explore new therapeutic applications, thereby reinforcing its commitment to innovation.
4. Education and Training: An essential aspect of Nevros operations involves educating healthcare providers and patients alike about the capabilities of their products and the science behind chronic pain management.
Products
Nevro Corps product lineup is centered around the high-frequency spinal cord stimulation technology, with the Senza system being the flagship offering. Here’s a closer look at the specific products:
1. Senza Spinal Cord Stimulation System:
- Neurostimulator: A compact implantable device that delivers high-frequency electrical impulses targeting the spinal cord.
- Handheld Remote Control: Patients can control and adjust the stimulator settings based on their comfort levels and pain management needs.
2. Senza Omnia:
- This system offers customizable stimulation parameters, enabling healthcare providers to tailor therapy for individual patient needs in a more personalized approach.
3. Senza II:
- An upgraded version of the original Senza system featuring enhanced battery life and improved therapeutic outcomes, designed to extend the usability and functionality for patients.
4. HF10 Therapy:
- Utilizes a proprietary waveforms technology, designed to provide effective pain relief without the undesirable sensations of paresthesia, which can be a common side effect of traditional stimulation methods.
5. Senza SCS:
- Specifically targeted toward patients with a high pain burden, this spinal cord stimulation system is optimized for those who may not have achieved adequate relief from conventional pain management strategies.
6. Accessories and Consumables:
- Nevro provides various accessories that support the operation of its devices, ensuring patients have the necessary tools for optimal use.
Services
Complementing its product offerings, Nevro Corp extends a range of services that enhance the overall patient experience and optimize clinical outcomes:
1. Clinical Research:
- Nevro engages in rigorous, ongoing research to validate the effectiveness of its products and explore new therapeutic possibilities, ensuring that its offerings remain at the forefront of medical innovation.
2. Physician Training:
- The company provides extensive training and certification programs for healthcare providers to ensure they are well-equipped to integrate Nevros technologies into their practices.
3. Patient Education:
- A suite of educational resources is available to help patients navigate their treatment options, understand the mechanisms of their therapies, and make informed decisions regarding their chronic pain management.
4. Technical Support:
- Dedicated technical support services are in place to assist both patients and healthcare providers with any operational inquiries or troubleshooting needs concerning the Senza system.
5. Patient Advocacy:
- Nevro is deeply committed to advocating for chronic pain sufferers, working collaboratively with patient advocacy groups to elevate awareness about the challenges faced by this population and promote resources for support.
Conclusion
In summary, Nevro Corp stands as a leader in the field of chronic pain management through its innovative products and comprehensive services. The Senza system, along with its associated offerings, highlight the companys dedication to providing effective and personalized pain relief solutions. By concentrating on ongoing clinical research, comprehensive education, and unwavering patient advocacy, Nevro strives to not only alleviate suffering but also enhance the quality of life for individuals facing the challenges of chronic pain.